Program

4th Annual Biopharmaceutical Research & Development Symposium
University of Nebraska Medical Center, Omaha, NE, USA
September 7-8, 2017

Venue:  
UNMC Center for Drug Discovery
Lozier Center for Pharmacy Sciences and Education
Address:  Room 2006
4040 Emile Street, Omaha, NE

Time

Topic

Speaker

Additional Comments

Thursday, September 7, 2017
Session Chair: Chittibabu (Babu) Guda, UNMC College of Medicine

8:00-8:30am

Check-in

8:40-8:50am

Welcome & Introduction of the Symposium

Ram Mahato, Ph.D. Chair, Dept of PharmSci, UNMC

8:50-9:20am

Research breakthroughs in pharmaceutical sciences

Vincent H.L. Lee, Ph.D.

The Chinese University of Hong Kong, Hong Kong

9:20 -9:45am

Defining Genome-wide Activity of CRISPR-Cas Nucleases for Therapeutics Shengdar Tsai, Ph.D. St. Jude Children's Research Hospital, USA

9:45-10:15am

Stem cell-engineered invariant natural killer T-cells for cancer therapy Lili Yang, Ph.D. University of California, USA

10:15-10:25

Break

10:25-10:55am

Non-viral CRISPR/Cas gene editing enabled by co-delivery of mRNA and sgRNA inside of synthetic lipid nanoparticles Daniel J. Siegwart, Ph.D. University of Texas Southwestern Medical Center, USA

10:55am-11:25am

Chemical enhancement of CRISPR/Cas9 mediated sitespecific genome engineering using novel inhibitors of the Ku-DNA interaction Katherine Pawelczak, Ph.D. NERx Biosciences, USA

11:25-11:30am

Group photo at the Ice Rink
11:30am-12:30pm Lunch break

Session Chair: Jered Garrison, UNMC College of Pharmacy

12:30-1:00pm

CRISPR: a versatile tool for both forward and reverse genetics research Channabasavaiah Gurumurthy, Ph.D. University of Nebraska Medical Center, USA

1:00-1:30pm

Efficient homology-directed repair using long single-stranded DNA templates

Rolf Turk, Ph.D. Integrated DNA Technologies, USA

1:30-2:00pm

The Ethical Issues of CRISPR/Cas9 Technology: Aspiring Towards Perfection or Annihilation?

Carol Szczepaniak Nebraska Coalition for Ethical Research (NCER) President

2:00-2:45pm

Poster session in commons area of College of Pharmacy center for Drug Discovery
Judges: Joseph Vetro, Corey Hopkins and Martin Conda-Sheridan, UNMC College of Pharmacy

2:45-3:15pm

Exosome-based nucleic acid drug delivery for cancer immunotherapy Yoshinobu Takakura, Ph.D. Kyoto University, Japan

Session Chair: Jered Garrison, UNMC College of Pharmacy

3:15-4:55pm

Oral presentations from Graduate Students/Postdocs

Four speakers

15 min each

3:45-3:55pm

Break

4:55pm

Closing remarks

Tatiana Bronich, Ph.D.

Professor and Co-director, Nebraska Center for Nanomedicine

Friday, September 8, 2017
 
 Session Chair: Cheng Kun, UMKC College of Pharmacy, Kansas City

8:15-9:00am

Check-in and Breakfast

9:00-9:30am

Elimination of HIV-1 DNA by CRISPR Technology in Living Animals

Kamel Khalili, Ph.D. Temple University, USA

9:30-10:00am

Design of novel biomaterials for drug delivery

Jianzhong Du, Ph.D. Tongji University, China

10:00-10:30am

Stimuli-responsive nanomedicine for anticancer therapy

Won Jong Kim, Ph.D. Pohang University of Science and Technology, South Korea

10:30-10:40am

Break

10:40-11:10am

Exosomes in Precision Medicine: Cancer Detection and Monitoring using Liquid Biopsy Blood Testing

Andrew Godwin, Ph.D. University of Kansas Medical Center

11:10-11:30am

Intellectual Properties and Commercialization of Nanomedicines

Michael Dixon, Ph.D. UNeMed Corporation, University of Nebraska Medical Center, USA
11:30am Closing remarks and awards for poster and oral presentation (students/postdocs) Courtney Fletcher, Pharm.D. Dean and Professor, UNMC College of Pharmacy

12:00pm

Sack lunches provided following closing remarks - 2nd floor Pharmacy Drug Discovery